Used as an intermediate in the synthesis of pharmaceutical compounds, particularly in the development of active pharmaceutical ingredients (APIs) targeting central nervous system disorders. Its structure supports the creation of bioactive molecules with potential antipsychotic, antidepressant, or anxiolytic properties. Also employed in research settings to design novel piperazine-based derivatives for drug discovery.